Zhejiang Gongdong Medical Technology Co., Ltd.

SHSE:605369 Stock Report

Market Cap: CN¥5.0b

Zhejiang Gongdong Medical Technology Future Growth

Future criteria checks 5/6

Zhejiang Gongdong Medical Technology is forecast to grow earnings and revenue by 32.9% and 24% per annum respectively. EPS is expected to grow by 32.9% per annum. Return on equity is forecast to be 16.1% in 3 years.

Key information

32.9%

Earnings growth rate

32.9%

EPS growth rate

Medical Equipment earnings growth22.6%
Revenue growth rate24.0%
Future return on equity16.1%
Analyst coverage

Low

Last updated13 Jun 2024

Recent future growth updates

No updates

Recent updates

Zhejiang Gongdong Medical Technology Co., Ltd.'s (SHSE:605369) P/E Still Appears To Be Reasonable

Jun 07
Zhejiang Gongdong Medical Technology Co., Ltd.'s (SHSE:605369) P/E Still Appears To Be Reasonable

Estimating The Intrinsic Value Of Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369)

Mar 28
Estimating The Intrinsic Value Of Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369)

Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369) Looks Just Right With A 27% Price Jump

Mar 06
Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369) Looks Just Right With A 27% Price Jump

Zhejiang Gongdong Medical Technology (SHSE:605369) Is Reinvesting At Lower Rates Of Return

Feb 27
Zhejiang Gongdong Medical Technology (SHSE:605369) Is Reinvesting At Lower Rates Of Return

Earnings and Revenue Growth Forecasts

SHSE:605369 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,0933824915442
12/31/20251,7343143644252
12/31/20241,4362531964152
3/31/20241,02112589188N/A
12/31/202397510964185N/A
9/30/20231,006103105208N/A
6/30/20231,128176136248N/A
3/31/20231,347260143268N/A
12/31/20221,469326111283N/A
9/30/20221,527367138382N/A
6/30/20221,4173443285N/A
3/31/20221,28032732350N/A
12/31/20211,19431197373N/A
9/30/20211,088319326269N/A
6/30/20211,068313208379N/A
3/31/2021989281177304N/A
12/31/2020830226134242N/A
9/30/2020744191-160220N/A
6/30/202063815558142N/A
3/31/202052911320113N/A
12/31/201955311420122N/A
12/31/20184838667102N/A
12/31/201743154N/A86N/A
12/31/201637161N/A86N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 605369's forecast earnings growth (32.9% per year) is above the savings rate (2.9%).

Earnings vs Market: 605369's earnings (32.9% per year) are forecast to grow faster than the CN market (22.7% per year).

High Growth Earnings: 605369's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 605369's revenue (24% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 605369's revenue (24% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 605369's Return on Equity is forecast to be low in 3 years time (16.1%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.